Source link : https://www.newshealth.biz/health-news/semaglutide-kidney-benefits-extend-to-those-without-diabetes/
STOCKHOLM — Improvements in kidney function outcomes observed with glucagon-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes extend to patients who are overweight or obese but don’t yet have type 2 diabetes, new research shows. “These data are important because they are the first data to suggest a kidney benefit of semaglutide […]
Author : News Health
Publish date : 2024-05-26 15:07:35
Copyright for syndicated content belongs to the linked Source.